SCHEMBL12304343

SCHEMBL12304343

FC(F)(F)c1ccc(CNc2ccc(CC3CNc4ncc(Cl)cc43)cn2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 3/20 0.43
▸ KIT P10721 2/20 0.43
▸ SLC6A4 P31645 2/20 0.42
▸ LCK P06239 1/20 0.42
▸ PGR P06401 1/20 0.42
▸ CHRM2 P08172 1/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ ADRA2A P08913 1/20 0.42
▸ PDGFRB P09619 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ PDGFRA P16234 1/20 0.42
▸ FLT1 P17948 1/20 0.42
▸ DRD1 P21728 1/20 0.42
▸ TBXA2R P21731 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ ADORA1 P30542 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ OPRM1 P35372 1/20 0.42
▸ DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24594059 0.90 CSF1R (0.54) CSF1RKITSLC6A4LCKPGR
SCHEMBL13056388 0.85 CSF1R (0.52) CSF1RKITCCNT1CCND3CDK6
SCHEMBL12925721 0.80 CACNA1B (0.44) CSF1RKITKCNH2
SCHEMBL12342109 0.80 CSF1R (0.42) CSF1RKITCCND3CDK6NPC1
SCHEMBL14236264 0.79 VNN1 (0.42) SLC6A4ALDH1A1MAPTHDAC1HDAC6
SCHEMBL14236211 0.79 HDAC1 (0.38) SLC6A4KDRCCNT1ALDH1A1HDAC4
SCHEMBL14236085 0.79 RPS6KB1 (0.45) CSF1RKITKDRFLT3AURKB
SCHEMBL12304080 0.78 VNN1 (0.41) SLC6A4CCNT1HDAC4HDAC1HDAC6
SCHEMBL12646947 0.78 KDM4E (0.48) CSF1RKITNPC1RAB9AALDH1A1
SCHEMBL14236271 0.77 VNN1 (0.41) SLC6A4ALDH1A1HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230482-A1 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY PLEXXIKON INC. 2011-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230482-A1 COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY KIT, FLT3, FER CSF1R 10/4885KIT 1/4885SLC6A4 3954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback